Tempo Scan Pacific Overview
- Year Founded
-
1953
- Status
-
Public
- Employees
-
4,370
- Stock Symbol
-
TSPC
- Investments
-
1
- Share Price
-
$0.12
- (As of Monday Closing)
Tempo Scan Pacific General Information
Description
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.
Contact Information
Website
www.temposcangroup.comCorporate Office
- Jalan H.R. Rasuna Said Kavling 3-4
- Tempo Scan Tower, 16th Floor
- Jakarta, 12950
- Indonesia
Corporate Office
- Jalan H.R. Rasuna Said Kavling 3-4
- Tempo Scan Tower, 16th Floor
- Jakarta, 12950
- Indonesia
Tempo Scan Pacific Stock Performance
As of 16-Nov-2026, Tempo Scan Pacific’s stock price is $0.12. Its current market cap is $554M with 4.51B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.12 | $0.12 | $0.12 - $0.19 | $554M | 4.51B | 677K | $0.02 |
Tempo Scan Pacific Financials Summary
As of 30-Sep-2026, Tempo Scan Pacific has a trailing 12-month revenue of $862M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 442,534 | 561,775 | 533,792 | 384,237 |
| Revenue | 861,902 | 848,719 | 859,610 | 859,989 |
| EBITDA | 105,776 | 119,321 | 131,372 | 117,566 |
| Net Income | 76,583 | 85,251 | 91,140 | 77,179 |
| Total Assets | 803,301 | 782,001 | 763,589 | 724,671 |
| Total Debt | 73,523 | 63,397 | 52,510 | 71,495 |
Tempo Scan Pacific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tempo Scan Pacific Signals
Tempo Scan Pacific Investments (1)
Tempo Scan Pacific’s most recent deal was a Joint Venture with PT Tempo CTTQ Biopharmaceutical Indonesia. The deal was made on 24-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PT Tempo CTTQ Biopharmaceutical Indonesia | 24-Jul-2026 | Joint Venture | Practice Management (Healthcare) |
Tempo Scan Pacific ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Tempo Scan Pacific FAQs
-
When was Tempo Scan Pacific founded?
Tempo Scan Pacific was founded in 1953.
-
Where is Tempo Scan Pacific headquartered?
Tempo Scan Pacific is headquartered in Jakarta, Indonesia.
-
What is the size of Tempo Scan Pacific?
Tempo Scan Pacific has 4,370 total employees.
-
What industry is Tempo Scan Pacific in?
Tempo Scan Pacific’s primary industry is Pharmaceuticals.
-
Is Tempo Scan Pacific a private or public company?
Tempo Scan Pacific is a Public company.
-
What is Tempo Scan Pacific’s stock symbol?
The ticker symbol for Tempo Scan Pacific is TSPC.
-
What is the current stock price of Tempo Scan Pacific?
As of 16-Nov-2026 the stock price of Tempo Scan Pacific is $0.12.
-
What is the current market cap of Tempo Scan Pacific?
The current market capitalization of Tempo Scan Pacific is $554M.
-
What is Tempo Scan Pacific’s current revenue?
The trailing twelve month revenue for Tempo Scan Pacific is $862M.
-
What is Tempo Scan Pacific’s annual earnings per share (EPS)?
Tempo Scan Pacific’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process